Our read is that individuals should get a colonoscopy, with experts advocating for aggressive and frequent screening due to its high efficacy in preventing colon cancer.
Our read is that colonoscopies are a well-supported method for preventing colon cancer, which experts state is 100% preventable because every colon cancer originates from a polyp detectable during the procedure.
Experts suggest starting colonoscopies around age 40, or earlier for those with specific risk factors, and recommend a frequency more often than every five to ten years, with some advocating for every one to three years.
While generally considered safe, individuals should weigh their personal risk-reward tradeoff and cost-benefit analysis when determining screening frequency.
Fecal occult blood testing and fecal DNA tests are sensible precursors to colonoscopy for colorectal cancer surveillance. More frequent colonoscopy surveillance may be warranted if polyps are present or if the bowel preparation is incomplete.
Peter Attia and Rhonda Patrick (3x) note that risks of colonoscopy include electrolyte abnormalities from bowel preps and sedation. Peter Attia (1x) points out that cancer can develop as soon as six to eight months after a normal colonoscopy. Rhonda Patrick (1x) mentions that standard colonoscopy recommendations have shifted to starting at age 45, with some debate on 5-10 year intervals. Peter Attia (1x) also states that colonoscopy screening every 10 years shows a statistically significant benefit in reducing colon cancer and mortality, but with minimal clinical significance.
New evidence suggesting that the risks of complications from colonoscopies outweigh the benefits, or that alternative screening methods offer comparable or superior efficacy with fewer risks, would change the verdict. Additionally, if experts were to widely agree on less frequent screening intervals without a significant increase in cancer incidence, this could also alter the recommendation.
The effect size is large enough to matter clinically, not just statistically.
Benefits hold across the populations where it's been tested.
The intervention improves the primary outcome at standard doses in healthy adults.
The effect size is large enough to matter clinically, not just statistically.
The recommended age for a first colonoscopy for individuals with no history of colon cancer is 40.
Most of the support comes from short or small studies.
Animal-model results don't translate to the human protocol being recommended.
Animal-model results don't translate to the human protocol being recommended.
Most of the support comes from short or small studies.
Confounding and publication bias inflate the apparent benefit.